Bone Loss Completed Phase 2 Trials for Zoledronic acid (DB00399)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01228318Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)Treatment
NCT00181584Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate CancerPrevention